Clinical trials by condition
Progressive supranuclear palsy (PSP) clinical trials near you
15 studies for progressive supranuclear palsy (PSP) are recruiting volunteers at 54 research sites in 24 states.
Also called Steele-Richardson-Olszewski syndrome.
- Studies recruiting
- 15
- Research sites
- 54
- States
- 24
What is progressive supranuclear palsy (PSP)?
Progressive supranuclear palsy, or PSP, is a rare brain disease caused by damage to nerve cells in the brain. It affects movement, including control of walking and balance, and it also affects thinking and eye movement. It is progressive, which means it gets worse over time.
The cause of PSP is unknown; in rare cases it is caused by a change in a certain gene. One sign of it is abnormal clumps of a protein called tau in nerve cells in the brain. It usually affects people over 60. Losing balance while walking is often the first symptom. Others can include problems with speech and swallowing, blurred vision, trouble controlling eye movement, and changes in mood and behavior.
There is currently no effective treatment for PSP. Medicines may reduce some symptoms, and aids such as walking aids and special glasses may also help. People with severe swallowing problems may need surgery to place a feeding tube into the stomach.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus
Areas with the most progressive supranuclear palsy (PSP) studies
Metro areas where studies for progressive supranuclear palsy (PSP) are recruiting, each study counted once in an area.
By state
Studies for progressive supranuclear palsy (PSP) recruiting in each state.
- Pennsylvania5 studies · 2 sites
- Texas4 studies · 6 sites
- California3 studies · 6 sites
- Colorado3 studies · 3 sites
- Florida3 studies · 4 sites
- Massachusetts3 studies · 1 site
- Maryland3 studies · 4 sites
- Minnesota3 studies · 2 sites
- New York3 studies · 5 sites
- Washington3 studies · 3 sites
Whom the studies accept
The share of the progressive supranuclear palsy (PSP) studies open to each group. A study can accept several.
- Adults 18 to 64100%
- Adults 65 and over100%
- Children and teens (under 18)13%
- Healthy volunteers40%
- Open to all sexes100%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Early phase 17%
- Phase 1/27%
- Phase 27%
- Phase 37%
- No phase (device, behavioral and other studies)20%
- Not stated53%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Progressive supranuclear palsy (PSP) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/progressive-supranuclear-palsy, updated November 13, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/progressive-supranuclear-palsy">LocalTrial, Progressive supranuclear palsy (PSP) clinical trials near you</a>, updated November 13, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study progressive supranuclear palsy (PSP). A study is counted once however many sites it has.
Updated November 13, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the progressive supranuclear palsy (PSP) studies near you that may fit. Free and private.
Ready to see what's near you?
Find progressive supranuclear palsy (PSP) studies near me